The design of pharmaceutical water systems has always been part science and part alchemy, and unfortunately, it is not likely
to change in the near future. Daily rhetoric is rife with statements from informed and intelligent people alleging design
requirements that do not actually exist.
The problem is that if you do not have documentation from a reliable source that supports or contradicts these statements,
they are nearly impossible to refute. As a result, they are often incorporated into system design.
Take, for example, the use of bacteria-retentive filtration in a water system. For years, variants of the following alleged
statement have circulated verbally: "FDA doesn't allow filters because it considers them to be band-aids on a badly designed
system." As a result, many systems were designed without filters, rooted in a fear that the US Food and Drug Administration
would disapprove. Meltzer et al., after researching this very subject, wrote that current FDA staffers indicated they would not disapprove a system simply
because it contained these filters (1). Was this statement ever really made?
The answer is a qualified yes, as this author personally heard it numerous times from more than one FDA employee, albeit many
years ago. None-theless, it was said in conversation and never written in an approved regulatory document or guide. Written guidelines . . . or lack thereof
As far back as FDA's 1993 Guide to Inspections of High Purity Water Systems, one can find comments that, taken out of context, could be interpreted as support for either side of the argument.
For example, in that Guide, Section "X-Reverse Osmosis," paragraph 6 states, "The systems also contain 0.2 micron point of
use filters which can mask the level of microbial contamination in the system" (2). It also goes on in the same paragraph
to state, "If filters are used in a water system there should be a stated purpose for the filter, i.e., particulate removal
or microbial reduction, and an SOP stating the frequency with which the filter is to be changed" (2).
Hence, in spite of the urban legend, it does not appear that FDA ever took a definitively negative stance against bacteria-retentive
filtration, although some individual inspectors did so, possibly based on a specific system design or set of individualized
circumstances.
What's missing.The normally accepted design criteria for US Pharmacopeia (USP) water systems (purified and water-for-injection) are neither
published by FDA nor are they tabularized in a recognized volume for easy review and discussion, although much is written
about them by industry pundits. Nonetheless, most or all of the writings include at least some of the items listed in the
sidebar, "Commonly accepted design criteria for USP water systems." Some of the items listed in the sidebar are supported
in reliable resources, but many are not, and few confirmations exist in regulatory print.
Regardless of whether these items are documented in the literature or not, they are very often accepted by owners, engineers,
designers, users, validation experts, and operations personnel as rules or laws.
The good news is that none of these features, properly applied, have ever compromised a water system, although some absolutists
have come very close. Consider the example of the engineer who insisted an 1100-ft long, 2-in. line be pitched ⅛ in./ft even
though the roof elevation was only 12 ft (it took a contractor with a jackhammer to make the point).
Microbial control. What is paramount and possibly not obvious is that of the items listed in the sidebar, every one relates either directly or
indirectly to microbial control or sanitization of the system.
The reason for so much focus on sanitization is that achieving the required chemical purity for USP waters (they're basically
the same for purified and water-for-injection) is fairly simple with available technologies. Keeping the system under microbiologic
control, however, takes finesse.